CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2010-06, Vol.149 (5), p.795-796
Hauptverfasser:	Lee, Cindy, Guinn, Barbara‐ann, Brooks, Suzanne E., Richardson, Deborah, Orchard, Kim
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Antigens, CD - metabolism Antigens, Neoplasm - metabolism Biological and medical sciences CD66 Cell Adhesion Molecules - metabolism Female Hematologic and hematopoietic diseases Humans Immunodeficiencies. Immunoglobulinopathies Immunoglobulinopathies Immunopathology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Middle Aged multiple myeloma Multiple Myeloma - immunology plasma cells Plasma Cells - immunology Radioimmunotherapy - methods targeted radiotherapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!